[REGN] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 246.76%
YoY- 12.60%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,952,000 1,828,200 2,169,500 2,048,400 1,933,700 1,711,800 1,927,800 0.83%
PBT 918,900 668,600 889,800 768,500 224,700 546,100 676,200 22.70%
Tax 21,600 44,000 97,800 98,900 31,600 85,000 -144,200 -
NP 897,300 624,600 792,000 669,600 193,100 461,100 820,400 6.16%
Tax Rate -2.35% -6.58% -10.99% -12.87% -14.06% -15.56% 21.33% -
Total Cost 1,054,700 1,203,600 1,377,500 1,378,800 1,740,600 1,250,700 1,107,400 -3.20%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 45.97 34.16 36.51 32.69 9.99 26.94 42.56 5.27%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.30%
EPS Diluted 7.61 5.43 6.93 5.86 1.68 3.99 7.15 4.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.